Performance-enhancing drugs, simply put, are different substances, procedures, or chemical agents that are designed to offer advantages during athletic performance. These drugs affect the body in various ways, such as increasing the oxygen-carrying capacity of the blood and also enlarge muscles. Performance-enhancing drugs helps the body in recovering from workouts quickly. This drug can be taken as a topical treatment, injection, or a pill.
The global performance-enhancing drugs market is predicted to grow at a 4.8% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report.
On the contrary, the use of performance enhancing drugs leads to numerous side effects such as heart attack and masculinization and heart attack in females, and diminished sperm production and acne in males. This may impact the performance enhancing drugs market growth over the forecast period.
Regional Analysis
Based on the region, the performance-enhancing drugs market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa. Of these, the Americas will dominate the market over the forecast period. This is owing to the presence of well-developed economies having high per capita income, especially in Canada and the US, the two major contributors of the region. Moreover, the rising prevalence of breast cancer incidences is likely to push market growth as anabolic steroids is used for treating various forms of breast cancer.
The performance-enhancing drugs market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to rising acceptance of performance-enhancing drugs in the region and the accessibility of funds for R&D activities.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/4695
Market Segmentation
The Market Research Future report provides a wide segmental analysis of the performance enhancing drugs market based on products, types, and end users.
Based on types, the performance enhancing drugs market is segmented into nootropic, ergogenic aids, and others. The ergogenic aids segment is again segmented into human growth hormone, dehydroepiandrosterone (DHEA), anabolic steroids, and others. The nootropic segment is further segmented into choline and acetylcholine intermediates, ampakines, racetams, and others.
Based on products, the performance enhancing drugs market is segmented into patches, injections, pills, and others.
Have Any Query? Connect with Our Research Expert 24*7:https://www.marketresearchfuture.com/enquiry/4695
Key Players
Leading players profiled in the performance enhancing drugs market report include Eli Lilly and Company. (US), Onnit Labs, LLC. (US), Douglas Laboratories. (US), BrainAlert, LLC (US), Novo Nordisk A/S (Europe), AstraZeneca (Europe), Bayer AG (Europe), Balkan Pharmaceuticals (Europe), and Taj Pharmaceuticals Limited (India), among others. The major players in the market have acquired several strategies to strengthen their position and also create a footprint in the market. These include acquisitions, partnerships, joint ventures, agreements, high expense on R&D activities, market initiatives, clinical trials, new product launches, and others.
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.